Availability, Prices and Affordability of Antibiotics Stocked by Informal Providers in Rural India: A Cross-Sectional Survey.

AWaRe access affordability antibiotics informal providers markups medicine prices private sector rural India watch

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
14 Apr 2022
Historique:
received: 18 02 2022
revised: 04 04 2022
accepted: 09 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Providers without formal training deliver healthcare and antibiotics across rural India, but little is known about the antibiotics that they stock. We conducted a cross-sectional survey of such informal providers (IPs) in two districts of West Bengal, and assessed the availability of the antibiotics, as well as their sales volumes, retail prices, percentage markups for IPs and affordability. Of the 196 IPs that stocked antibiotics, 85% stocked tablets, 74% stocked syrups/suspensions/drops and 18% stocked injections. Across all the IPs, 42 antibiotic active ingredients were stocked, which comprised 278 branded generics from 74 manufacturers. The top five active ingredients that were stocked were amoxicillin potassium clavulanate (52% of the IPs), cefixime (39%), amoxicillin (33%), azithromycin (25%) and ciprofloxacin (21%). By the WHO's AWaRe classification, 71% of the IPs stocked an ACCESS antibiotic and 84% stocked a WATCH antibiotic. The median prices were in line with the government ceiling prices, but with substantial variation between the lowest and highest priced brands. The most affordable among the top five tablets were ciprofloxacin, azithromycin, cefixime and amoxicillin (US$ 0.8, 0.9, 1.9 and 1.9 per course), and the most affordable among the syrups/suspensions/drops were azithromycin and ofloxacin (US$ 1.7 and 4.5 per course, respectively), which are mostly WATCH antibiotics. IPs are a key source of healthcare and antibiotics in rural communities; practical interventions that target IPs need to balance restricting WATCH antibiotics and expanding the basket of affordable ACCESS antibiotics.

Identifiants

pubmed: 35453278
pii: antibiotics11040523
doi: 10.3390/antibiotics11040523
pmc: PMC9026796
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Medical Research Council
ID : MR/P004512/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S013598/1
Pays : United Kingdom

Références

Science. 2016 Oct 7;354(6308):
pubmed: 27846471
PLoS One. 2019 May 31;14(5):e0217818
pubmed: 31150515
Lancet Infect Dis. 2011 Sep;11(9):692-701
pubmed: 21659004
Antibiotics (Basel). 2020 Nov 07;9(11):
pubmed: 33171743
BMJ. 2017 Sep 5;358:j2291
pubmed: 28874360
PLoS One. 2013;8(2):e54978
pubmed: 23405101
Sociol Health Illn. 2017 May;39(4):614-628
pubmed: 27910120
Health Policy Plan. 2014 Jul;29 Suppl 1:i20-9
pubmed: 25012795
Soc Sci Med. 2021 Apr;275:113813
pubmed: 33721743
Lancet. 2016 Jan 9;387(10014):168-75
pubmed: 26603918
Acta Trop. 2016 Dec;164:455-462
pubmed: 27771418
BMJ Glob Health. 2019 Apr 11;4(2):e001315
pubmed: 31139449
Bull World Health Organ. 2000;78(1):135-43
pubmed: 10686748
WHO South East Asia J Public Health. 2016 Sep;5(2):133-140
pubmed: 28607241
JAC Antimicrob Resist. 2020 Sep;2(3):dlaa048
pubmed: 32974610
J Infect. 2019 Jan;78(1):8-18
pubmed: 29981773
BMC Health Serv Res. 2011 Dec 28;11:351
pubmed: 22204447
BMC Health Serv Res. 2020 Jul 15;20(1):656
pubmed: 32669092
Lancet Infect Dis. 2021 Jan;21(1):107-115
pubmed: 32717205
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
PLoS Med. 2007 Mar 27;4(3):e82
pubmed: 17388660
J Perinatol. 2017 Aug;37(8):911-921
pubmed: 28492525
J Family Med Prim Care. 2021 Mar;10(3):1404-1411
pubmed: 34041186
Soc Sci Med. 2003 Oct;57(7):1147-61
pubmed: 12899900
Soc Sci Med. 2010 Nov;71(9):1593-600
pubmed: 20855143
Lancet. 2016 Aug 6;388(10044):596-605
pubmed: 27358253
Malar J. 2013 Feb 05;12:52
pubmed: 23383972
Bull World Health Organ. 2020 Mar 01;98(3):177-187C
pubmed: 32132752
BMJ Glob Health. 2017 Sep 22;2(3):e000457
pubmed: 29018588
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
PLoS One. 2020 Jan 7;15(1):e0227515
pubmed: 31910444
BMJ Glob Health. 2019 Sep 20;4(5):e001787
pubmed: 31637030
Lancet Glob Health. 2021 May;9(5):e610-e619
pubmed: 33713630
BMC Int Health Hum Rights. 2010 Jul 06;10:18
pubmed: 20602805
Indian J Pharmacol. 2016 Jul-Aug;48(4):347-349
pubmed: 27756941
J Pharm Policy Pract. 2019 Jul 17;12:20
pubmed: 31346472
Antibiotics (Basel). 2019 Sep 05;8(3):
pubmed: 31491900
BMJ Open. 2021 Dec 3;11(12):e052435
pubmed: 34862290

Auteurs

Meenakshi Gautham (M)

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Rosalind Miller (R)

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Sonia Rego (S)

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Catherine Goodman (C)

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Classifications MeSH